Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC

Clinical trial NCT06863311 · RECRUITING

Trial details

NCT number: NCT06863311
Sponsor: Karie Runcie
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Renal Cell Carcinoma Metastatic Renal Cell Carcinoma Clear Cell Renal Cell Carcinoma

Start date: 2026-03-13
Primary completion: 2027-12-31
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.